Compare · DFTX vs FTLF
DFTX vs FTLF
Side-by-side comparison of Definium Therapeutics Inc. (DFTX) and FitLife Brands Inc. (FTLF): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DFTX and FTLF operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $4.83B, about 46.5x FTLF ($103.9M).
- Over the past year, DFTX is up 345.2% and FTLF is down 11.9% - DFTX leads by 357.1 points.
- DFTX has hit the wire 5 times in the past 4 weeks while FTLF has been quiet.
- DFTX has more recent analyst coverage (5 ratings vs 2 for FTLF).
PerformanceDFTX+345.17%FTLF-11.90%
2025-07-21+0.00%2026-07-17
- Company
- Definium Therapeutics Inc.
- FitLife Brands Inc.
- Price
- $44.25+0.35%
- $11.10+1.56%
- Market cap
- $4.83B
- $103.9M
- 1M return
- +83.23%
- +7.35%
- 1Y return
- +345.17%
- -11.90%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- News (4w)
- 5
- 0
- Recent ratings
- 5
- 2
Latest DFTX
- Big Pharma Just Paid Up to $3.8 Billion for Psychedelic Medicine, and the Rest of the Sector Is Being Repriced in Real Time
- Definium Therapeutics Launches Wired for Worry, a Health Care Provider Initiative to Advance the Understanding of Generalized Anxiety Disorder (GAD) Patient Impact and Neurobiology
- New Healthcare Claims Study Published in CNS Spectrums Finds High Rates of Treatment Switching, Discontinuation, and Prolonged Gaps in Care Among Patients with Generalized Anxiety Disorder (GAD)
- Definium Therapeutics Announces New Employee Inducement Grants
- Multi-Billion-Dollar Battle for the Future of Depression Treatment Has Begun Creating a Huge Opportunity
- Chief Legal Officer Sullivan Mark sold $585,750 worth of shares (13,008 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 320,571 units (SEC Form 4) (withholding tax)
- Chief Medical Officer Karlin Daniel sold $451,876 worth of shares (10,035 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 503,282 units (SEC Form 4) (withholding obligation)
- Chief Financial Officer Roberts Brandi sold $135,675 worth of shares (3,013 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 1% to 209,487 units (SEC Form 4) (withholding obligation)
- Chief Executive Officer Barrow Robert sold $1,315,236 worth of shares (29,208 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 3% to 1,098,246 units (SEC Form 4) to satisfy withholding obligation
- Chief Commercial Officer Wiley Matthew T. sold $129,101 worth of shares (2,867 units at $45.03) as part of a pre-agreed trading plan, decreasing direct ownership by 2% to 174,633 units (SEC Form 4) (withholding obligation)
Latest FTLF
- SEC Form DEFA14A filed by FitLife Brands Inc.
- SEC Form DEFA14A filed by FitLife Brands Inc.
- SEC Form DEF 14A filed by FitLife Brands Inc.
- Joey Chestnut Teams Up with Dr. Tobias for New Campaign: "Cleanse Like a Winner"
- FitLife Brands Inc. filed SEC Form 8-K: Leadership Update
- SEC Form 4 filed by President Hansen Ryan P.
- FitLife Brands Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form 10-Q filed by FitLife Brands Inc.
- FitLife Brands Announces First Quarter 2026 Results
- FitLife Brands Announces First Quarter Earnings Call